Lucinactant for the prevention of respiratory distress syndrome in premature infants.
about
The Future of Bronchopulmonary Dysplasia: Emerging Pathophysiological Concepts and Potential New Avenues of Treatment.Surfactant therapy for neonatal respiratory distress syndrome in 2013.Parental preferences regarding administration of an animal-derived versus a synthetic medication to newborn infants.
P2860
Lucinactant for the prevention of respiratory distress syndrome in premature infants.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lucinactant for the prevention of respiratory distress syndrome in premature infants.
@en
type
label
Lucinactant for the prevention of respiratory distress syndrome in premature infants.
@en
prefLabel
Lucinactant for the prevention of respiratory distress syndrome in premature infants.
@en
P2860
P356
P1476
Lucinactant for the prevention of respiratory distress syndrome in premature infants
@en
P2093
Steven M Donn
P2860
P304
P356
10.1586/ECP.12.80
P407
P577
2013-03-01T00:00:00Z